Published in J Urol on November 01, 1977
Renal cell carcinoma seeding of a percutaneous biopsy tract. Can Urol Assoc J (2013) 1.17
Needle tract seeding following percutaneous biopsy of renal cell carcinoma. Korean J Urol (2015) 0.88
Image-guided urological interventions: What the urologists must know. Indian J Urol (2015) 0.78
Papillary Renal Cell Carcinoma Seeding along a Percutaneous Biopsy Tract. Case Rep Urol (2015) 0.75
Renal Cell Carcinoma Metastasis from Biopsy Associated Hematoma Disruption during Robotic Partial Nephrectomy. Case Rep Urol (2014) 0.75
Celiac plexus block: a roentgenographic, anatomic study of technique and spread of solution in patients and corpses. Anesth Analg (1981) 1.75
Latent carcinoma of the prostate--why the controversy? J Urol (1974) 1.48
Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological Association. J Urol (1995) 1.47
The future of research in genitourinary radiology: through the looking glass--a view from the Society of Uroradiology. Radiology (1998) 1.41
Is deleting the digital rectal examination a good idea? West J Med (1991) 1.38
Treatment of adverse contrast media reaction. Radiology (1995) 1.38
Comparison of real-time cholecystosonography and oral cholecystography. Radiology (1980) 1.36
Pneumoscrotum after blunt chest trauma. J Emerg Med (1995) 1.27
Experience with triple-drug therapy in a pharmacological erection program. J Urol (1993) 1.09
Adverse effects of contrast media: incidence, prevention and management. Drug Saf (1998) 1.04
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone. Cancer (1983) 1.04
Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation. Invest Urol (1978) 1.03
Gracilis muscle flap for closure of rectourethral fistula. J Urol (1979) 1.03
Endourological treatment of ureteroenteric strictures: efficacy of Acucise endoureterotomy. J Urol (1999) 1.00
Total prostatectomy for localized prostatic cancer. J Urol (1984) 0.98
Kidney stone removal: percutaneous versus surgical lithotomy. J Urol (1985) 0.97
Cystic pheochromocytoma. Urology (1985) 0.95
Endopyelotomy: review of results and complications. J Urol (1991) 0.94
Experience with indwelling ureteral stent catheters. J Urol (1976) 0.93
The development of fibrin sheath on indwelling venous catheters. Surg Gynecol Obstet (1973) 0.92
Needle tract seeding of renal cell carcinoma. AJR Am J Roentgenol (1977) 0.91
Reno-colic and reno-colic-cutaneous fistula: report of 3 cases. J Urol (1965) 0.90
Primary adenocarcinoma of bladder. Urology (1980) 0.90
Pubovaginal slings using fascia lata for the treatment of intrinsic sphincter deficiency. J Urol (1997) 0.89
Extracorporeal shock-wave lithotripsy for bile duct calculi. Am J Surg (1998) 0.89
Adjuvant radiotherapy following radical prostatectomy: results and complications. J Urol (1986) 0.88
Hyperbaric oxygen therapy for radiation-induced hemorrhagic cystitis. J Urol (1993) 0.88
Manifestations of renal cell carcinoma. Urology (1976) 0.88
Chemotherapy of advanced prostatic cancer by the National Prostatic Cancer Group. Semin Oncol (1976) 0.88
Indeterminate renal masses. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.85
Renal cell carcinoma staging. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.84
A new method for percutaneous nephrostomy. Radiology (1976) 0.84
Mechanical reliability, surgical complications, and patient and partner satisfaction of the modern three-piece inflatable penile prosthesis. Urology (1998) 0.83
A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostate. J Urol (1981) 0.83
Prostate cancer. Chemotherapy. Cancer (1987) 0.83
Microvascular management of multiple renal arteries in transplantation. J Urol (1982) 0.83
Renal artery origins: location and distribution in the transverse plane at CT. Radiology (1997) 0.82
Radiation dose to personnel during percutaneous renal calculus removal. AJR Am J Roentgenol (1985) 0.82
Chemotherapy of advanced prostatic cancer. Evaluation of response parameters. Urology (1976) 0.82
Radiation exposure to patient and urologist during percutaneous nephrostolithotomy. J Urol (1984) 0.82
Arteriovenous fistula of the renal vessels: Surgical management. J Urol (1975) 0.82
Imaging in acute pyelonephritis. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.82
The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate. J Urol (1976) 0.82
Caliceal calculi. J Urol (1986) 0.81
Adjuvant therapy for localized prostate cancer. Cancer (1993) 0.81
Total prostatectomy for stage B carcinoma of the prostate. J Urol (1977) 0.81
Adjuvant therapy for clinical localized prostate cancer treated with surgery or irradiation. Eur Urol (1996) 0.80
Diagnostic approach to renal trauma. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.80
Prolonged continuous intravenous infusion interleukin-2 and lymphokine-activated killer-cell therapy for metastatic renal cell carcinoma. J Clin Oncol (1992) 0.80
Adverse reactions to radiographic contrast material. West J Med (1980) 0.80
Digital subtraction rotational angiography for aneurysms of the intracranial anterior circulation: injection method and optimization. AJNR Am J Neuroradiol (1996) 0.79
Endopyelotomy for primary repair of ureteropelvic junction obstruction. J Urol (1988) 0.79
Adenomyosis of the gastric antrum in children. Radiology (1974) 0.79
Carcinoma of the prostate: local control with external beam radiation therapy. J Urol (1979) 0.79
Experience with indwelling silicone rubber ureteral catheters. J Urol (1974) 0.79
Acute onset flank pain, suspicion of stone disease. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.79
Post-treatment follow-up of prostate cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.78
Surgical management of renal lesions using in situ hypothermia and ischemia. J Urol (1976) 0.78
Prognosis in stage D-1 prostate cancer relative to anatomic sites of nodal metastases. National Prostatic Cancer Treatment Group. Cancer (1989) 0.78
Clinical significance of serum alkaline phosphatase isoenzyme levels in advanced prostatic carcinoma. J Urol (1978) 0.78
Chemotherapy of advanced prostatic carcinoma with cyclophosphamide or 5-fluorouracil: results of first national randomized study. J Urol (1975) 0.78
Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer. J Urol (1983) 0.78
Granulomatous prostatitis: confusion clinically with carcinoma of the prostate. J Urol (1977) 0.77
Quality control of radiation therapy in multi-institutional randomized clinical trial for localized prostate cancer. Urology (1988) 0.77
Gibbons ureteral stents. Urol Clin North Am (1982) 0.77
Morbidity of radical perineal prostatectomy following transurethral resection of the prostate. J Urol (1984) 0.77
Renal pelvic tumors. J Urol (1975) 0.77
Recurrent lower urinary tract infections in women. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.77
The prophylactic use--or misuse--of antibiotics in transurethral prostatectomy. J Urol (1978) 0.76
Follow-up imaging of bladder carcinoma. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.76
Obstructive voiding symptoms secondary to prostate disease. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.76
Comparison of procarbazine, imidazole-carboxamide and cyclophosphamide in relapsing patients with advanced carcinoma of the prostate. J Urol (1979) 0.76
A comparison of estramustine phosphate and streptozotocin in patients with advanced prostatic carcinoma who have had extensive irradiation. J Urol (1977) 0.76
Acute onset of scrotal pain (without trauma, without antecedent mass). American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.76
Transcatheter occlusive therapy of genitourinary abnormalities using isobutyl 2-cyanoacrylate (Bucrylate). AJR Am J Roentgenol (1979) 0.76
Radiologic investigation of patients with renovascular hypertension. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.76
Pretreatment staging of clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.76
Extracorporeal shock wave lithotripsy for obstructing pancreatic duct calculi. J Urol (1997) 0.76
Pretreatment staging of invasive transitional cell carcinoma of the bladder. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.76
The incidentally discovered adrenal mass. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.76
The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate. Trans Am Assoc Genitourin Surg (1976) 0.76
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation. Trans Am Assoc Genitourin Surg (1978) 0.76
Radiologic investigation of patients with hematuria. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.76
Staging of testicular malignancy. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.76
Follow-up of renal cell carcinoma. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.76
Extracorporeal shock-wave lithotripsy (ESWL) of pelvic kidney calculus. Use of C-arm fluoroscopy for correct patient positioning. Urology (1987) 0.76
Determination of serum creatinine level before intravenous administration of iodinated contrast medium. A survey. Invest Radiol (1995) 0.76
Renal artery origins: best angiographic projection angles. Radiology (1997) 0.75
Segmental resection in the management of bladder carcinoma. J Urol (1978) 0.75
Advances in the treatment of metastatic prostatic cancer. West J Med (1985) 0.75